Air quality and COVID-19
RIVM will be researching whether air quality affects the course and severity of COVID-19 in the Netherlands.
Applying behavioural science to COVID-19
Human behaviour is important in gaining control of COVID-19. By researching behaviour and health, RIVM gains insights that can help people keep following the recommendations and rules.
Coronavirus monitoring in sewage
The coronavirus SARS-CoV-2 enters the sewage system via human faeces. Coronavirus monitoring in sewage enables early detection, making it possible for RIVM to map the spread of the virus.
Families and young people (First Few Hundred Study)
RIVM is carrying out research among families in the Netherlands where someone has contracted the coronavirus SARS-CoV-2. We want to find out more about the course of the disease.
How the coronavirus spreads indoors
RIVM National Institute for Public Health and the Environment and UMC Groningen will be measuring how the coronavirus SARS-CoV-2 spreads in an indoor space. The study will also look at how far the virus can spread and whether the virus particles are still contagious over longer distances.
Research on how the coronavirus spreads indoors.
Immunity to COVID-19
How does the human immune system respond after a SARS-CoV-2 infection or vaccination against the coronavirus SARS-CoV-2? RIVM is conducting various studies on this topic.
Indirect effects of COVID-19 on health and healthcare
The COVID-19 epidemic and the measures to control the virus have led to major shifts in healthcare. RIVM is mapping out these effects.
Using an Infection Radar (based on a weekly survey), RIVM monitors whether people in the Netherlands have symptoms that could indicate an infection with the coronavirus SARS-CoV-2. (Results only available in Dutch.)
Long COVID Study
RIVM is researching how many people who get COVID-19 still have symptoms in the longer term, exactly what those symptoms are, and how serious they are.
Monitoring stations at GP practices
The Netherlands Institute for Health Services Research (Nivel) is working with RIVM on screening for people with flu-like symptoms. Working together, they are running tests at 40 General Practitioner (GP) practices to see how often these symptoms occur and which viruses are causing these symptoms.
Older people living at home and the impact of COVID-19
The COVID-19 epidemic and the related measures affect everyone. That includes older people living at home. RIVM is taking stock of how they are doing.
Different variants (mutations) of the coronavirus SARS-CoV-2 have been circulating in the Netherlands since spring of 2020. RIVM is conducting laboratory research to see how the virus is changing and what this means for the spread of the virus in the Netherlands.
Prevention & care in the context of broader issues in society
In collaboration with the Netherlands Organisation for Health Research and Development (ZonMw), RIVM periodically publishes a summary of research results from studies related to COVID-19 in the field of prevention & care and broader issues in society.
Q fever and COVID-19
RIVM is researching whether people who previously had Q fever have an increased risk of contracting COVID-19.
Risk factors for COVID-19 (CONTEST study)
Why do some people become ill from the coronavirus SARS-CoV-2 while others do not? This and other risk factors for COVID-19 are being investigated by RIVM in collaboration with GGD-GHOR.
Transmission at primary schools
It is likely that children transmit the new variants of SARS-CoV-2 somewhat faster and more frequently. How much faster and more frequently? We do not know enough about this yet. To find out more, RIVM is researching how the virus spreads at primary schools.
Vaccine-induced protection against severe illness
RIVM is also monitoring vaccine effectiveness in preventing illness (COVID-19), transmission of the coronavirus SARS-CoV-2, and hospital and ICU admission.
More COVID-19 research in the Netherlands
RIVM is not alone in its efforts; many research studies on COVID-19 are being conducted in the Netherlands outside RIVM. An overview can be found on the FMS website. Also, new research programmes on COVID-19 have been set up with the help of government grants. See the website of the Netherlands Organisation for Health Research and Development (ZonMw) for more information about the ZonMw COVID-19 programme.
COVID-19 research in EU projects
UMC Utrecht, Utrecht University, RIVM , the Netherlands Pharmacovigilance Centre Lareb and research institute PHARMO are involved in the European project ACCESS (Vaccine COVID-19 monitoring ReadinESS). Read more.
RIVM and Radboud University Medical Centre are collaborating on the PANDEM-2 project. This project aims to increase and strengthen preparedness for and response to future pandemics. In that context, sharing information and collaborating are very important in order to protect the health and safety of people across the European Union. The PANDEM-2 project is funded by the European Union through Horizon 2020. The team from the Netherlands includes experts from Radboudumc and RIVM. Read the Radboudumc press release (in Dutch).